Dr. Sai Kishore S - Consultant – Nuclear Medicine

Dr. Sai Kishore S – Nuclear Medicine and Theranostics Specialist in Chennai

Nuclear Medicine

4 years

Fortis Hospital, Gleneagles Chennai, Chennai
5.0★★★★★1 review

Dr. Sai Kishore S – Nuclear Medicine Specialist in Chennai

Dr. Sai Kishore S is a Consultant in Nuclear Medicine at Gleneagles Hospital, Chennai, with four years of professional experience. His expertise includes molecular imaging, PET/CT, SPECT/CT and theranostics, which combines diagnostic nuclear medicine with targeted radionuclide treatment.

His qualifications include MBBS and MD. His professional training and clinical practice encompass diagnostic and therapeutic nuclear medicine, radiopharmaceutical preparation, radiation safety and the interpretation of advanced molecular imaging studies.

Dr. Sai Kishore S has experience in PET/CT and SPECT/CT imaging, which provide information about biological activity and anatomical structures. His clinical interests include oncological imaging, cardiac PET, infection imaging and metabolic brain imaging.

His expertise also includes radionuclide therapies such as Lutetium-177 PSMA therapy, Lutetium-177 DOTATATE therapy, radioactive iodine treatment and Y-90 skin patch brachytherapy. These treatments are considered for selected conditions after careful evaluation of diagnosis and patient suitability.

Dr. Sai Kishore S has documented experience with PET/CT-guided biopsy and PET-based radiotherapy planning. Such techniques may support tissue sampling and coordinated cancer treatment planning by providing molecular imaging information.

His professional interests extend to nuclear medicine research, theranostic applications and instrument development. At Gleneagles Hospital, Chennai, he contributes advanced molecular imaging and targeted radionuclide therapy expertise to multidisciplinary patient care.

Other Information

PET/CT Imaging

Positron emission tomography combined with computed tomography provides information about metabolic or molecular activity alongside detailed anatomical images. PET/CT may be used in selected cancers, inflammatory conditions and other disorders. The radiotracer and imaging protocol depend on the clinical indication and patient requirements.

SPECT/CT Imaging

Single-photon emission computed tomography combined with CT uses radioactive tracers to evaluate selected physiological processes and anatomical structures. The technique may assist in investigating bone, cardiac and other medical conditions. Imaging findings are interpreted alongside clinical information and related investigations.

Nuclear Medicine Theranostics

Theranostics combines molecular imaging with targeted radionuclide treatment. Imaging helps identify whether a particular biological target is present and may support treatment selection. The approach is used for selected medical conditions and requires specialist assessment, monitoring and radiation safety measures.

Lutetium-177 PSMA Therapy

Lutetium-177 PSMA therapy is a targeted radionuclide treatment used for selected patients with prostate cancer. A radioactive medicine binds to prostate-specific membrane antigen expressed by suitable tumour cells. Eligibility depends on cancer characteristics, molecular imaging, previous treatment and clinical criteria.

Lutetium-177 DOTATATE Therapy

Lutetium-177 DOTATATE therapy, also called peptide receptor radionuclide therapy, is used for selected neuroendocrine tumours expressing somatostatin receptors. Molecular imaging helps establish suitability. Treatment requires monitoring for potential kidney, bone marrow and other treatment-related effects.

Radioactive Iodine (I-131) Therapy

Radioactive iodine therapy uses iodine-131 for selected thyroid disorders, including certain thyroid cancers and hyperthyroidism. Treatment suitability depends on the diagnosis, thyroid function and other clinical factors. Patients receive appropriate radiation safety instructions and follow-up recommendations.

Oncological PET Imaging

Oncological PET imaging assesses the distribution of selected radiotracers within the body to provide information relevant to cancer evaluation. Depending on the cancer type, it may assist in staging, treatment response assessment or suspected recurrence. Imaging findings require interpretation within the clinical context.

Cardiac PET Imaging

Cardiac PET imaging uses radiotracers to evaluate selected aspects of heart function and myocardial blood flow or metabolism. It may be considered for particular cardiovascular conditions. The imaging protocol and interpretation depend on the clinical indication and specialist assessment.

Infection Imaging

Nuclear medicine infection imaging helps identify metabolic or inflammatory activity associated with selected suspected infections. Different radiotracers and imaging methods may be used depending on the condition. Results are considered alongside examination, laboratory tests and other diagnostic findings.

Metabolic Brain Imaging

Metabolic brain imaging uses specialised radiotracers to examine selected patterns of brain activity. It may contribute information during evaluation of certain neurological disorders. Interpretation requires consideration of symptoms, neurological findings and other imaging investigations.

PET/CT-Guided Biopsy

PET/CT-guided biopsy uses molecular and anatomical imaging to help select or access an appropriate tissue sampling target. The collected sample is examined in a laboratory to establish or clarify a diagnosis. The procedure is considered when clinically appropriate and technically feasible.

PET-Based Radiotherapy Planning

PET-based radiotherapy planning incorporates molecular imaging information into selected cancer radiation treatment plans. Imaging may help identify metabolically active tumour areas and support target definition. Treatment planning is coordinated with radiation oncology and other relevant specialist teams.

Y-90 Skin Patch Brachytherapy

Yttrium-90 skin patch brachytherapy uses a radioactive source placed close to selected superficial treatment targets. It is considered only for appropriate indications following specialist assessment. Treatment planning includes evaluation of the affected area, radiation dose and surrounding healthy skin.

Radiopharmaceutical Preparation and Quality Control

Radiopharmaceutical preparation involves handling radioactive substances used for diagnostic imaging or treatment. Quality control procedures help verify suitable preparation and compliance with relevant safety standards. These activities require trained personnel, appropriate facilities and established radiation protection procedures.

Education & Qualifications

MBBS, MD

Services

PET/CT imaging, SPECT/CT imaging, molecular imaging, theranostics, Lu-177 PSMA therapy, Lu-177 DOTATATE therapy, I-131 therapy, Y-90 skin patch brachytherapy, oncology PET imaging, cardiac PET imaging, infection imaging, metabolic brain imaging, PET/CT-guided biopsy, PET-based radiotherapy planning, radiopharmaceutical quality control and radiation safety.

Patient Testimonials

What Patients Say About Dr. Sai Kishore S

Genuine patient experiences and treatment feedback.

5.0
1 review
A

Arun Kumar

Verified

Chennai • PET/CT Imaging Consultation

5.0

Understanding Molecular Imaging

I consulted Dr. Sai Kishore S about PET/CT imaging. The discussion explained how molecular and anatomical information may help clinical evaluation. I found the explanation useful for understanding the purpose of the scan.

Frequently Asked Questions

Quick answers to common questions about Dr. Sai Kishore S

01

What is Dr. Sai Kishore S's speciality?

He specialises in Nuclear Medicine, PET/CT, SPECT/CT and theranostics.

02

How many years of experience does he have?

The official hospital profile lists four years.

03

What are his qualifications?

MBBS and MD, according to the hospital. The MD speciality is not specified in the education field.

04

Does he have experience in PET/CT and SPECT/CT imaging?

Yes. Both are documented in his professional biography.

05

Does he have expertise in Lu-177 PSMA therapy?

Yes. Lu-177 PSMA therapy is listed among his radionuclide therapy interests.

Still have questions about Dr. Dr. Sai Kishore S?

Contact us for personalized help or to schedule an appointment.